RESULT_COUNT: 224,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
LOXO,LOXO:US,BBG005CWWQG4,"Commit To Purchase Loxo Oncology At $70, Earn 10.2% Annualized Using Options",2017-10-19 16:48:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T1LtQLEtjuQ/commit-to-purchase-loxo-oncology-at-70-earn-102-annualized-using-options-cm862055,Investors considering a purchase of Loxo Oncology Inc Symbol LOXO shares but tentative about paying the going market price of 86 46 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces Positive Top-Line Results from Independent Review Committee Assessment of Larotrectinib Dataset,2017-10-18 10:00:00 +0000,https://finance.yahoo.com/news/loxo-oncology-announces-positive-top-100000377.html?.tsrc=rss,"–75% Overall Response Rate by Independent Review; 80% Overall Response Rate by Investigator Assessment–. STAMFORD, Conn., Oct. 18, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the ..."
LOXO,LOXO:US,BBG005CWWQG4,See what the IHS Markit Score report has to say about Loxo Oncology Inc.,2017-10-17 12:04:14 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120414911.html?.tsrc=rss,Loxo Oncology Inc NASDAQ NMS:LOXO
LOXO,LOXO:US,BBG005CWWQG4,Buying And Selling Stocks Right Are Keys To This Top Mutual Fund's Success,2017-10-16 13:18:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lW-8hJhOEQA/buying-and-selling-stocks-right-are-keys-to-this-top-mutual-funds-success-cm859982,Victory RS Small Cap Growth Fund RSEGX has been a dominant force among small growth stock funds in 2017 RS Investments chief investment officer Scott Tracy and his team have delivered a stellar performance with a focus on risk adjusted returns Mr Tracy comanages the 1 6
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Fights Cancer With 'Tumor Agnostic' Approach,2017-10-16 13:18:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZWZQE2Dkqv4/loxo-oncology-fights-cancer-with-tumor-agnostic-approach-cm859981,The potential cancer cure disclosures that propelled Loxo Oncology LOXO stock up 43 one day in June and an additional 15 one day in September indicate innovation in cancer research and treatment that many investors say could keep Loxo aloft ibd display video id
LOXO,LOXO:US,BBG005CWWQG4,6 Top Biotech Companies In Innovation Earn Recognition In New Awards,2017-10-16 12:01:09 +0000,http://finance.yahoo.com/r/6c7c83e3-cdcb-3b9b-a44f-7114dc6f5297/top-biotech-companies-innovation-6-biotech-stocks-recognized?src=A00220&yptr=yahoo&.tsrc=rss,Cancer. Alzheimer’s. MS. Treatments from the fast-growing U.S. biotech industry provide new hope for patients. What are the top biotech companies in innovation?
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Fights Cancer With &apos;Tumor Agnostic&apos; Approach,2017-10-16 11:48:25 +0000,http://finance.yahoo.com/r/9d3708b8-28da-3747-bf4d-3fb2bae521e0/loxo-oncology-cancer-treatment-and-research-approach?src=A00220&yptr=yahoo&.tsrc=rss,Loxo Oncology uses gene sequencing to develop its so-called precision medicine as it pushes the envelope in cancer research and cancer treatment.
LOXO,LOXO:US,BBG005CWWQG4,Buying And Selling Stocks Right Are Keys To This Top Mutual Fund&apos;s Success,2017-10-16 11:47:23 +0000,http://finance.yahoo.com/r/f77cf83d-1f62-3cba-a8aa-263d660eb5e4/buying-selling-stocks-right-keys-to-top-mutual-funds-success?src=A00220&yptr=yahoo&.tsrc=rss,Victory RS Small Cap Growth Fund uses quantitative analysis to find stocks with potential for big gains
LOXO,LOXO:US,BBG005CWWQG4,See what the IHS Markit Score report has to say about Loxo Oncology Inc.,2017-10-12 12:05:30 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120530528.html?.tsrc=rss,Loxo Oncology Inc NASDAQ NMS:LOXO
LOXO,LOXO:US,BBG005CWWQG4,"BGNE Hits Record High, SYRS Awaits Catalysts, ALT To Report Data In Q4",2017-10-09 21:33:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6GlMZ2lj2pU/bgne-hits-record-high-syrs-awaits-catalysts-alt-to-report-data-in-q4-20171009-01000,"BGNE Hits Record High, SYRS Awaits Catalysts, ALT To Report Data In Q4"
LOXO,LOXO:US,BBG005CWWQG4,See what the IHS Markit Score report has to say about Loxo Oncology Inc.,2017-10-09 12:05:37 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120537941.html?.tsrc=rss,Loxo Oncology Inc NASDAQ NMS:LOXO
LOXO,LOXO:US,BBG005CWWQG4,See what the IHS Markit Score report has to say about Loxo Oncology Inc.,2017-10-04 12:05:18 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120510723.html?.tsrc=rss,Loxo Oncology Inc NASDAQ NMS:LOXO
LOXO,LOXO:US,BBG005CWWQG4,See what the IHS Markit Score report has to say about Loxo Oncology Inc.,2017-10-03 12:05:18 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120518990.html?.tsrc=rss,Short interest is moderate for LOXO with between 5 and 10% of shares outstanding currently on loan.  The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.
LOXO,LOXO:US,BBG005CWWQG4,How Does Investing In Loxo Oncology Inc (LOXO) Impact Your Portfolio?,2017-09-29 12:42:08 +0000,https://finance.yahoo.com/news/does-investing-loxo-oncology-inc-124208878.html?.tsrc=rss,"If you are a shareholder in Loxo Oncology Inc’s (NASDAQ:LOXO), or are thinking about investing in the company, knowing how it contributes to the risk and reward profile of yourRead More..."
LOXO,LOXO:US,BBG005CWWQG4,Today's Research Reports on Stocks to Watch: Zynerba Pharmaceuticals and Loxo Oncology,2017-09-29 12:10:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-121000021.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 29, 2017 / Zynerba scored a big win yesterday after announcing positive results from its trial of ZYN002, a cannabidiol gel that is aimed to reduce symptoms of fragile ..."
LOXO,LOXO:US,BBG005CWWQG4,"Health Care Sector Update for 09/28/2017: LOXO,ZYNE,DXCM",2017-09-28 20:34:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pHzZqN9j9kc/health-care-sector-update-for-09282017-loxozynedxcm-cm852817,Top Health Care StocksTop Health Care Stocks JNJ 0 33 JNJ 0 33 PFE 0 38 PFE 0 38 ABT 2 82 ABT 2 82 MRK 0 50 MRK 0 50 AMGN 0 26 AMGN 0 26 Health care stocks were unable to hold on to most of their earlier rise with the NYSE Health Care Index still showing a 0 3 increase
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces Details of LOXO-292 Abstract to be Presented as Late-Breaking Presentation at the IASLC 18th World Conference on Lung Cancer,2017-09-27 21:46:03 +0000,https://finance.yahoo.com/news/loxo-oncology-announces-details-loxo-214603136.html?.tsrc=rss,"STAMFORD, Conn., Sept. 27, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, announced details ..."
LOXO,LOXO:US,BBG005CWWQG4,A Peek Into The Future For Mirati Therapeutics,2017-09-19 17:31:43 +0000,https://finance.yahoo.com/news/peek-future-mirati-therapeutics-173143492.html?.tsrc=rss,"Citigroup in a note released Monday, delved into the roadmap for Mirati Therapeutics, Inc. (NASDAQ: MRTX ). The firm feels the response for its targeted agent sitravatinib in CBL-mutated non-small cell ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology's Up 230% in the Past Year -- Can You Still Make Money Buying It?,2017-09-17 13:36:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Cn0s72jvxUQ/loxo-oncologys-up-230-in-the-past-year-can-you-still-make-money-buying-it-cm846794,Loxo Oncology NASDAQ LOXO 160 is one of biotech s best performing stars this past year and shares could still have room to run higher if the FDA cooperates with an OK for its lead drug larotrectinib A busy summer After updating investors on larotrectinib s efficacy
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology&apos;s Up 230% in the Past Year -- Can You Still Make Money Buying It?,2017-09-17 12:01:00 +0000,http://finance.yahoo.com/r/f1624b5d-3fb4-394e-bb73-c9e22a8702d9/loxo-oncology-is-up-230-in-the-past-year-can-you-s.aspx?yptr=yahoo&.tsrc=rss,"The company has plenty of cash on its balance sheet and a cancer drug that could soon make its way to the FDA, but you&apos;ll pay dearly to buy its shares."
LOXO,LOXO:US,BBG005CWWQG4,HALO Just Got Brighter - What Other Pharma Stocks Made News This Week?,2017-09-15 02:11:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x8i9EL_bHw8/halo-just-got-brighter--what-other-pharma-stocks-made-news-this-week-20170915-00044,HALO Just Got Brighter - What Other Pharma Stocks Made News This Week?
LOXO,LOXO:US,BBG005CWWQG4,Dolby Laboratories is a stock to watch after Apple’s new iPhone launch,2017-09-14 18:29:42 +0000,http://finance.yahoo.com/r/fac02885-b703-382c-bf2c-2cbdb206e509/Story.aspx?guid=CA99488A-9978-11E7-8EBC-4ADA47F6D2CA&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Also in focus: Juno Therapeutics, Loxo Oncology and NovoCure. By Harry Boxer."
LOXO,LOXO:US,BBG005CWWQG4,"TTOO Catches Investors' Eyes, SIEN Shaping Up, AGTC Slips Into Red",2017-09-13 22:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uBXaniUPgaE/ttoo-catches-investors-eyes-sien-shaping-up-agtc-slips-into-red-20170913-01349,"TTOO Catches Investors' Eyes, SIEN Shaping Up, AGTC Slips Into Red"
LOXO,LOXO:US,BBG005CWWQG4,Why This Cancer Biotech Leads Pack After Hitting Record High,2017-09-13 20:33:28 +0000,http://finance.yahoo.com/r/97a23999-2e56-3f02-8cf6-23192c60a0ef/why-this-cancer-biotech-leads-pack-after-hitting-record-high?src=A00220&yptr=yahoo&.tsrc=rss,"Loxo rocketed to an all-time high on word it will present data from a Phase 1 trial in lung, thyroid, colon and solid-tumor cancers."
LOXO,LOXO:US,BBG005CWWQG4,"Health Care Sector Update for 09/13/2017: ITEK,LOXO,AGTC",2017-09-13 20:15:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YbqPgKBQDvc/health-care-sector-update-for-09132017-itekloxoagtc-cm845342,Top Health Care StocksTop Health Care Stocks JNJ 0 29 JNJ 0 29 PFE 1 05 PFE 1 05 ABT 0 59 ABT 0 59 MRK 0 09 MRK 0 09 AMGN 0 93 AMGN 0 93 Health care stocks added to their prior declines this afternoon with the NYSE Health Care Index declining almost 0 5 today while shares of
LOXO,LOXO:US,BBG005CWWQG4,"Health Care Sector Update for 09/13/2017: LXRX,LOXO,AGTC",2017-09-13 18:35:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SHhJ06cd5Cw/health-care-sector-update-for-09132017-lxrxloxoagtc-cm845280,Top Health Care StocksTop Health Care Stocks JNJ 0 44 JNJ 0 44 PFE 0 51 PFE 0 51 ABT 0 25 ABT 0 25 MRK 0 08 MRK 0 08 AMGN 1 58 AMGN 1 58 Health care stocks were trimming some of their prior declines with the NYSE Health Care Index declining almost 0 3 while shares of health
LOXO,LOXO:US,BBG005CWWQG4,Is It Time To Buy Loxo Oncology Inc (LOXO)?,2017-09-13 14:55:27 +0000,https://finance.yahoo.com/news/time-buy-loxo-oncology-inc-145527584.html?.tsrc=rss,"Loxo Oncology Inc (NASDAQ:LOXO), a pharmaceuticals, biotechnology and life sciences company based in United States, View our latest analysis for Loxo Oncology What’s the opportunity in LOXO? Great news forRead More..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces Initial LOXO-292 Clinical Data to be Presented as Late-Breaking Presentation at the IASLC 18th World Conference on Lung Cancer,2017-09-13 10:45:00 +0000,https://finance.yahoo.com/news/loxo-oncology-announces-initial-loxo-104500931.html?.tsrc=rss,"STAMFORD, Conn., Sept. 13, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, announced that ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology to Present at Upcoming Investor Conferences,2017-08-30 10:45:00 +0000,https://finance.yahoo.com/news/loxo-oncology-present-upcoming-investor-104500561.html?.tsrc=rss,"STAMFORD, Conn., Aug. 30, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced ..."
LOXO,LOXO:US,BBG005CWWQG4,See what the IHS Markit Score report has to say about Loxo Oncology Inc.,2017-08-22 12:02:57 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120257457.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
LOXO,LOXO:US,BBG005CWWQG4,See what the IHS Markit Score report has to say about Loxo Oncology Inc.,2017-08-21 12:03:11 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120311024.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
LOXO,LOXO:US,BBG005CWWQG4,See what the IHS Markit Score report has to say about Loxo Oncology Inc.,2017-08-18 12:03:05 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120338085.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
LOXO,LOXO:US,BBG005CWWQG4,See what the IHS Markit Score report has to say about Loxo Oncology Inc.,2017-08-17 12:03:28 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120328883.html?.tsrc=rss,Short interest is moderate for LOXO with between 5 and 10% of shares outstanding currently on loan.  The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  ETFs that hold LOXO had net inflows of $909 million over the last one-month.
LOXO,LOXO:US,BBG005CWWQG4,See what the IHS Markit Score report has to say about Loxo Oncology Inc.,2017-08-11 12:05:42 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120542139.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Over the last one-month, outflows of investor capital in ETFs holding LOXO totaled $994 million."
LOXO,LOXO:US,BBG005CWWQG4,See what the IHS Markit Score report has to say about Loxo Oncology Inc.,2017-08-10 12:05:16 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120516339.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Over the last one-month, outflows of investor capital in ETFs holding LOXO totaled $1.33 billion."
LOXO,LOXO:US,BBG005CWWQG4,3 Earnings Movers Among Our 4 Charts To Watch,2017-08-09 16:49:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w6uPmVK9hH4/3-earnings-movers-among-our-4-charts-to-watch-cm829641,"By Harry Boxer,  TheTechTrader.com       Here are four stocks looking strong technically and moving on earnings and other news.  Kite Pharma, Inc. ( KITE ) jumped to a new all-time high of $122.19 Tuesday after releasing quarterly results that beat Wall Street expectations.  The stock closed up $6.58, or 5.7%, to"
LOXO,LOXO:US,BBG005CWWQG4,Loxo reports 2Q loss,2017-08-09 01:57:20 +0000,https://finance.yahoo.com/news/loxo-reports-2q-loss-105243528.html?.tsrc=rss,"On a per-share basis, the Stamford, Connecticut-based company said it had a loss of $1.14. The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces Second Quarter 2017 Financial Results,2017-08-08 10:45:00 +0000,https://finance.yahoo.com/news/loxo-oncology-announces-second-quarter-104500465.html?.tsrc=rss,"–Larotrectinib NDA Submission on Track for Year End 2017/ Early 2018–. –Larotrectinib, LOXO-195, and LOXO-292 Clinical Trials Actively Enrolling–. –$467.6 million in Cash, Cash Equivalents, and Investments ..."
LOXO,LOXO:US,BBG005CWWQG4,LOXO Crosses Above Average Analyst Target,2017-08-03 15:02:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UJLVs1drDpg/loxo-crosses-above-average-analyst-target-cm826383,In recent trading shares of Loxo Oncology Inc Symbol LOXO have crossed above the average analyst 12 month target price of 71 33 changing hands for 71 80 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade on valuation
LOXO,LOXO:US,BBG005CWWQG4,Featured Company News - Loxo Oncology Acquires Reversible BTK Inhibitor Program from UK Biotech Firm Redx Pharma,2017-08-02 11:10:00 +0000,https://finance.yahoo.com/news/featured-company-news-loxo-oncology-111000523.html?.tsrc=rss,"Research Desk Line-up: Gilead Sciences Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 2, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Loxo ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology to Announce Second Quarter 2017 Financial Results,2017-08-01 10:45:00 +0000,https://finance.yahoo.com/news/loxo-oncology-announce-second-quarter-104500317.html?.tsrc=rss,"STAMFORD, Conn., Aug. 01, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, will announce financial ..."
LOXO,LOXO:US,BBG005CWWQG4,"Loxo Oncology Announces Acquisition of Highly Selective, Reversible BTK Inhibitor Program",2017-07-31 10:45:00 +0000,https://finance.yahoo.com/news/loxo-oncology-announces-acquisition-highly-104500487.html?.tsrc=rss,"STAMFORD, Conn., July 31, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced ..."
LOXO,LOXO:US,BBG005CWWQG4,These Biotechs Are Leading The Sector To A 3-Month High Today,2017-06-20 20:43:03 +0000,http://finance.yahoo.com/r/bb019aaa-2994-3817-b22d-d3c911ebc678/these-biotechs-are-leading-the-sector-to-a-3-month-high-today?src=A00220&yptr=yahoo&.tsrc=rss,"Shares of cancer-focused biotechs Bluebird, Clovis and Kite popped Tuesday, leading a sectorwide boom to a three-month high."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces the Closing of its Follow-On Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares,2017-06-20 20:01:00 +0000,https://finance.yahoo.com/news/loxo-oncology-announces-closing-offering-200100586.html?.tsrc=rss,"STAMFORD, Conn., June 20, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced ..."
LOXO,LOXO:US,BBG005CWWQG4,Trump drug pricing order may be weeks away,2017-06-20 18:25:35 +0000,https://finance.yahoo.com/news/trump-drug-pricing-order-may-182535062.html?.tsrc=rss,"Donald Trump plans to make good on drug pricing promises, but any action may be weeks away."
LOXO,LOXO:US,BBG005CWWQG4,Trump drug pricing order may be weeks away,2017-06-20 18:25:35 +0000,http://finance.yahoo.com/r/1c75e65a-e1b4-3a4a-8620-7fa0ff430c16/104540794?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104540794&yptr=yahoo&.tsrc=rss,"Donald Trump plans to make good on drug pricing promises, but any action may be weeks away."
LOXO,LOXO:US,BBG005CWWQG4,FDA to Clear Path for Drugs Aimed at Cancer-Causing Genes,2017-06-20 14:41:39 +0000,http://finance.yahoo.com/r/e959ac41-9811-34e0-8017-60bae0daaf9f/fda-moves-to-clear-path-for-drugs-aimed-at-cancer-causing-genes?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"For years, doctors have identified cancers by the affected body part: lung, breast, kidney. Now, in a long-awaited move, U.S. drug regulators will simplify the approval of treatments targeting specific ..."
LOXO,LOXO:US,BBG005CWWQG4,[$$] Loxo Strikes While the Biotech Iron is Hot,2017-06-16 04:09:42 +0000,http://finance.yahoo.com/r/e574c95c-0246-32e7-be21-45ebe2a0d892/loxo-strikes-while-the-biotech-iron-is-hot-1497541788?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,Biotech equity offerings at opportune moments maximize chances for commercial success.
LOXO,LOXO:US,BBG005CWWQG4,Cancer's Big Infrastructure Problem,2017-06-15 18:51:00 +0000,http://finance.yahoo.com/r/52011850-9230-3e93-8c3c-5021652a92a9/cancers-big-infrastructure-problem?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"We need to do more than just raise cancer drug prices yet again. We need to invest in the kind of infrastructure that will make it possible to test many of these medicines, and speed up innovation further."
LOXO,LOXO:US,BBG005CWWQG4,[$$] Loxo Strikes While the Biotech Iron is Hot,2017-06-15 18:50:36 +0000,http://finance.yahoo.com/r/e574c95c-0246-32e7-be21-45ebe2a0d892/loxo-strikes-while-the-biotech-iron-is-hot-1497541788?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Biotech equity offerings at opportune moments maximize chances for commercial success.
LOXO,LOXO:US,BBG005CWWQG4,"Loxo Oncology Shares Rally, Despite Diluting Investors",2017-06-15 14:10:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZrjWwwvOpBo/loxo-oncology-shares-rally-despite-diluting-investors-cm803736,Usually when a biotechnology company announces it s raising more money from investors the news causes shares to sell off However shares in Loxo Oncology NASDAQ LOXO 160 rallied despite the announcement of a shelf offering for an undisclosed number of shares The news
LOXO,LOXO:US,BBG005CWWQG4,"Loxo Oncology Shares Rally, Despite Diluting Investors",2017-06-15 12:00:00 +0000,http://finance.yahoo.com/r/4defc8be-10e6-3bf7-8bf8-e54c942be600/loxo-oncology-shares-rally-despite-diluting-invest.aspx?yptr=yahoo&.tsrc=rss,The company is issuing more stock to raise money to fund the development of its lead cancer drug.
LOXO,LOXO:US,BBG005CWWQG4,"ALDX Down But Not Out, BTX On Track, MNK Exploring New Use For Acthar",2017-06-15 02:26:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aXMjId0nzxE/aldx-down-but-not-out-btx-on-track-mnk-exploring-new-use-for-acthar-20170615-00053,"ALDX Down But Not Out, BTX On Track, MNK Exploring New Use For Acthar"
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Prices Follow-On Offering of Common Stock,2017-06-15 01:20:11 +0000,https://finance.yahoo.com/news/loxo-oncology-prices-offering-common-012011110.html?.tsrc=rss,"STAMFORD, Conn., June 14, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology launching secondary offering to fund drug research,2017-06-13 20:31:21 +0000,http://finance.yahoo.com/r/157c8c0e-e415-3a08-b3cf-0ebb0540dcf6/Story.aspx?guid=778AD8BC-C19C-47ED-9637-43B248542B9E&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Loxo Oncology Inc. shares slipped in the extended session Tuesday after the biotech said it was launching a secondary offering of an undisclosed number of shares. Loxo shares declined 2.2% to $72 after ...
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces Proposed Public Offering of Common Stock,2017-06-13 20:02:00 +0000,https://finance.yahoo.com/news/loxo-oncology-announces-proposed-public-200200601.html?.tsrc=rss,"STAMFORD, Conn., June 13, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, announced today ..."
LOXO,LOXO:US,BBG005CWWQG4,"Excitement from ASCO: TG Thereapeutics, Loxo Oncology, and Bluebird Bio",2017-06-13 15:30:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n_a-kdGyzFc/excitement-from-asco-tg-thereapeutics-loxo-oncology-and-bluebird-bio-cm802676,Clinical stage biotech companies put their best foot forward at the annual American Society of Clinical Oncology meeting earlier this week but while many companies released data it was presentations from bluebird bio NASDAQ BLUE TG Therapeutics NASDAQ TGTX and
LOXO,LOXO:US,BBG005CWWQG4,"Excitement from ASCO: TG Thereapeutics, Loxo Oncology, and Bluebird Bio",2017-06-13 13:29:00 +0000,http://finance.yahoo.com/r/780dd542-afa9-3c18-8f22-243958fa3931/industry-focus-healthcare-06-07-2017.aspx?yptr=yahoo&.tsrc=rss,"After presentations at the annual American Society of Clinical Oncology conference this week sent shares higher, investors in bluebird bio, TG Therapeutics, and Loxo Oncology are cheering."
LOXO,LOXO:US,BBG005CWWQG4,Precision Oncology Drug Shows Power Of Cancer Genomics,2017-06-09 10:30:00 +0000,http://finance.yahoo.com/r/e3f9bb3c-5166-3945-ade2-4a3a61389b58/precision-oncology-drug-shows-power-of-cancer-genomics?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"It’s a perfect example of how precision medicine can benefit patients with rare conditions. The key to the positive results is molecular matching. Patients received larotrectinib, a TRK inhibitor, only if their cancers were marked by a fusion involving a TRK gene."
LOXO,LOXO:US,BBG005CWWQG4,"Cramer Remix: What the dreaded rise in stocks, gold & Bitcoin means for your money",2017-06-07 22:59:59 +0000,http://finance.yahoo.com/r/27303107-daef-31c6-b7c0-39417bb40da7/104516177?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104516177&yptr=yahoo&.tsrc=rss,"Jim Cramer dissects one scary investment combination and how to play it, despite scary media headlines."
LOXO,LOXO:US,BBG005CWWQG4,LOXO Crosses Above Average Analyst Target,2017-06-06 15:04:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YllUQwl3mpY/loxo-crosses-above-average-analyst-target-cm799302,In recent trading shares of Loxo Oncology Inc Symbol LOXO have crossed above the average analyst 12 month target price of 54 33 changing hands for 70 12 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade on valuation
LOXO,LOXO:US,BBG005CWWQG4,"Gainers & Losers Of June 5: LOXO, CLSN, RDUS, GLYC, JUNO...",2017-06-05 22:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nkjIXwy7ShE/gainers--losers-of-june-5-loxo-clsn-rdus-glyc-juno-20170605-01326,"Gainers & Losers Of June 5: LOXO, CLSN, RDUS, GLYC, JUNO..."
LOXO,LOXO:US,BBG005CWWQG4,"Why Navistar International, Loxo Oncology, and Helix Energy Solutions Jumped Today",2017-06-05 22:01:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4RqwLgjgl2s/why-navistar-international-loxo-oncology-and-helix-energy-solutions-jumped-today-cm799011,Monday marked a quiet start to the week on Wall Street and major benchmarks finished close to where they started the day Market participants appeared content to tread water as they waited for geopolitical happenings to play out later this week including the potentially contentious U
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Inc (LOXO) Shares Skyrocket on Successful Cancer Drug Trial,2017-06-05 21:01:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VE5Vr-9gBvs/loxo-oncology-inc-loxo-shares-skyrocket-on-successful-cancer-drug-trial-cm799020,InvestorPlace Stock Market News Stock Advice amp Trading Tips Loxo Oncology Inc NASDAQ LOXO shares were in orbit on Monday following three successful cancer drug trials Source williami5 Via Flickr Loxo Oncology Inc reported positive results for its cancer
LOXO,LOXO:US,BBG005CWWQG4,"Update: Wall Street Backs Off Record Highs as Apple, Global Risks Weigh",2017-06-05 21:00:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NeIBuu86zZ4/update-wall-street-backs-off-record-highs-as-apple-global-risks-weigh-cm798992,Wall Street was muted on Monday starting the new week slightly in the red after ending the previous session at record highs as declines in Apple AAPL and global risks weighed ahead of a busy event driven week Wall Street was muted on Monday starting the new week slightly in the red
LOXO,LOXO:US,BBG005CWWQG4,Here Are Winners And Losers From Year&apos;s Biggest Cancer Meeting,2017-06-05 20:42:12 +0000,http://finance.yahoo.com/r/2cc13e4d-b2e0-365d-9414-f6650a5fed2c/here-are-the-winners-and-losers-from-the-years-primo-cancer-meeting?src=A00220&yptr=yahoo&.tsrc=rss,"Loxo Oncology stock defied a broad biotech dip Monday, spiking to a record high after unveiling data Saturday for its immuno-oncology drug."
LOXO,LOXO:US,BBG005CWWQG4,"Why Navistar International, Loxo Oncology, and Helix Energy Solutions Jumped Today",2017-06-05 20:30:00 +0000,http://finance.yahoo.com/r/3b55221b-f23c-381f-b918-7947d22560fd/why-navistar-international-loxo-oncology-and-helix.aspx?yptr=yahoo&.tsrc=rss,"Despite a flat day for the market, these stocks gained ground. Find out why."
LOXO,LOXO:US,BBG005CWWQG4,Here's Why Loxo Oncology Soared as Much as 58.5% Today,2017-06-05 19:02:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pUlPPFF8v98/heres-why-loxo-oncology-soared-as-much-as-585-today-cm798904,What happened Shares of Loxo Oncology NASDAQ LOXO soared nearly 59 today after the clinical stage biopharma announced interim data for three clinical trials over the weekend at the American Society of Clinical Oncology s annual meeting which is more commonly referred to
LOXO,LOXO:US,BBG005CWWQG4,Midday Update: Event Risk Weighs on Wall Street,2017-06-05 17:40:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3TPWexurnAQ/midday-update-event-risk-weighs-on-wall-street-cm798891,The benchmark averages were trading slightly lower at midday on Monday as investor s appetite for risk soured on recent geopolitical events and continued pressure on oil futures The S amp P 500 and Nasdaq Composite indices both set record highs but have backed off and were now in negative turf
LOXO,LOXO:US,BBG005CWWQG4,Here&apos;s Why Loxo Oncology Soared as Much as 58.5% Today,2017-06-05 17:33:00 +0000,http://finance.yahoo.com/r/ed113a39-ffc8-3d36-b34c-ff4e018afb5e/heres-why-loxo-oncology-soared-as-much-as-585-toda.aspx?yptr=yahoo&.tsrc=rss,The company announced interim data for three ongoing cancer trials.
LOXO,LOXO:US,BBG005CWWQG4,"Health Care Sector Update for 06/05/2017: JNJ, PFE, ABT, MRK, AMGN, CLSN, MBOT, LOXO",2017-06-05 16:40:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rjGBDhdhfMg/health-care-sector-update-for-06052017-jnj-pfe-abt-mrk-amgn-clsn-mbot-loxo-cm798838,Top Health Care stocks Top Health Care stocks JNJ 0 1 JNJ 0 1 PFE 0 8 PFE 0 8 ABT 0 3 ABT 0 3 MRK 1 1 MRK 1 1 AMGN 0 1 AMGN 0 1 Health care shares were mostly higher in mid day trade Monday Health care shares were mostly higher in mid day trade Monday In health
LOXO,LOXO:US,BBG005CWWQG4,Loxo stock soars on drug trial results: CEO,2017-06-05 16:32:00 +0000,https://finance.yahoo.com/video/loxo-stock-soars-drug-trial-163200484.html?.tsrc=rss,"CNBC's Meg Tirrell talks to Joshua Bilenker, CEO of Loxo Oncology, about the company's stock up 50% on the successful cancer drug trial live from the ASCO conference."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Pulls Back Off Best Levels But Remains Sharply Higher,2017-06-05 13:27:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YgngLlfc2ZE/loxo-oncology-pulls-back-off-best-levels-but-remains-sharply-higher-20170605-00925,Loxo Oncology Pulls Back Off Best Levels But Remains Sharply Higher
LOXO,LOXO:US,BBG005CWWQG4,"Biotech Movers: Loxo, NewLink, BioCryst",2017-06-05 13:25:00 +0000,http://finance.yahoo.com/r/d9d279b1-2597-3e31-9557-560c69f77877/biotech-movers-loxo-newlink-biocryst.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Loxo Oncology, NewLink Genetics and BioCryst Pharmaceuticals were among the biotech movers in premarket trading on Monday."
LOXO,LOXO:US,BBG005CWWQG4,"Pre-Market Most Active for Jun 5, 2017 :  FOR, SMFG, TOT, NOK, AAPL, PBYI, BABA, JCP, TLT, LOXO, QQQ, GLYC",2017-06-05 12:59:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fID82DnjtzY/pre-market-most-active-for-jun-5-2017-for-smfg-tot-nok-aapl-pbyi-baba-jcp-tlt-loxo-qqq-glyc-cm798535,The NASDAQ 100 Pre Market Indicator is down 4 61 to 5 876 85 The total Pre Market volume is currently 7 901 646 shares traded The following are the most active stocks for the pre market session Forestar Group Inc FOR is 1 85 at 16 05 with 2 192 385 shares traded
LOXO,LOXO:US,BBG005CWWQG4,ASCO: Loxo Oncology shares up on cancer drug announcement...,2017-06-05 12:51:00 +0000,https://finance.yahoo.com/video/asco-loxo-oncology-shares-cancer-125100511.html?.tsrc=rss,CNBC's Meg Tirrell reports the latest news on cancer research from the American Society of Clinical Oncology conference.
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology jumps 34% premarket on news of positive cancer drug trial,2017-06-05 11:49:58 +0000,https://finance.yahoo.com/news/loxo-oncology-jumps-34-premarket-114958143.html?.tsrc=rss,"Shares of Loxo Oncology Inc. rallied 34% in premarket trade Monday, after the company said its larotrectinib cancer drug succeeded in shrinking tumors in patients with a variety of cancers that share the ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology jumps 34% premarket on news of positive cancer drug trial,2017-06-05 11:49:58 +0000,http://finance.yahoo.com/r/5ec0848a-2cad-3897-af71-1e67c3a4a020/Story.aspx?guid=63F36CE3-30ED-400E-9B8E-AAB384D3B732&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Shares of Loxo Oncology Inc. rallied 34% in premarket trade Monday, after the company said its larotrectinib cancer drug succeeded in shrinking tumors in patients with a variety of cancers that share the ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Inc. (LOXO) Has Leaped To A New High After Publication,2017-06-05 09:39:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z6xirV7pIIE/loxo-oncology-inc-loxo-has-leaped-to-a-new-high-after-publication-20170605-00715,Loxo Oncology Inc. (LOXO) Has Leaped To A New High After Publication
LOXO,LOXO:US,BBG005CWWQG4,A New Cancer Drug Helped Almost Everyone Who Took It. Almost. Here's What It Teaches Us,2017-06-03 14:56:00 +0000,http://finance.yahoo.com/r/878537e7-582e-3f14-9d68-f8d473f8400e/a-new-cancer-drug-helped-almost-everyone-who-took-it-almost-heres-what-it-teaches-us?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Of the first 50 people, 38, or 76%, had clear shrinkage of their tumors. Of those, 30, or 79%, hadn’t had their tumors start growing or had new ones appear after 12 months of treatment, and are still on the drug."
LOXO,LOXO:US,BBG005CWWQG4,[$$] Experimental Drug Targets Genetic Defect Shared by Different Cancers,2017-06-03 11:30:04 +0000,http://finance.yahoo.com/r/7eaa8da6-4cb4-31ad-9b0c-8c1334513daa/experimental-drug-targets-same-genetic-defect-shared-by-different-cancers-1496489400?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,"An experimental drug shrank tumors in patients with a variety of cancers sharing the same genetic defect, new studies found, part of a push in oncology research to treat tumors by their molecular traits ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Drug Notches Strikingly High Response Rates in Genetically Defined Tumors,2017-06-03 11:30:00 +0000,http://finance.yahoo.com/r/feaaedd4-964a-3223-ada9-abe15950017d/loxo-drug-notches-strikingly-high-response-rates-in-genetically-defined-tumors.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The Loxo data also represent another advance for precision cancer medicine, in which patients are treated with drugs that target specific tumor mutations, regardless of where the cancer originates."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Breakthrough Therapy Larotrectinib Demonstrates 76 Percent Confirmed Objective Response Rate in TRK Fusion Adult and Pediatric Cancers as Presented at the American Society of Clinical Oncology Annual Meeting,2017-06-03 11:30:00 +0000,https://finance.yahoo.com/news/loxo-oncology-breakthrough-therapy-larotrectinib-113000401.html?.tsrc=rss,–Responses to Selective TRK Inhibitor Observed Across Tumor Types Harboring TRK Fusions–. –93 Percent of All Responding Patients Remain on Larotrectinib or Received Surgery with Curative Intent–. –Three ...
LOXO,LOXO:US,BBG005CWWQG4,Cancer Drug Targeting Rare Mutation Works Across Tumor Types,2017-06-03 11:30:00 +0000,http://finance.yahoo.com/r/85287bc4-05af-3079-bfe9-d5ff68b5bff3/cancer-drug-targeting-rare-mutation-works-across-tumor-types?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,Finding single therapies that can treat tumors based on their genetics rather than their location in the body has been a longstanding goal of medical research. A new drug may bring that a step closer to ...
LOXO,LOXO:US,BBG005CWWQG4,Loxo's targeted drug helps variety of advanced cancers in small study,2017-06-03 11:30:00 +0000,https://finance.yahoo.com/news/loxos-targeted-drug-helps-variety-113000788.html?.tsrc=rss,"Three quarters of patients with a wide  variety of advanced cancers responded to a Loxo Oncology Inc  therapy that targets a specific genetic defect,  according to data from a small study presented on Saturday at  the year's most important oncology meeting.  The drug, larotrectinib, directly targets an acquired rather  than inherited genetic defect called TRK fusions.  In such  patients, TRK genes abnormally attach to other genes, triggering  accelerated cancer cell growth."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces Clinical Proof of Concept Publication for Next-Generation TRK Inhibitor LOXO-195,2017-06-03 11:30:00 +0000,https://finance.yahoo.com/news/loxo-oncology-announces-clinical-proof-113000429.html?.tsrc=rss,"STAMFORD, Conn., June 03, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced ..."
LOXO,LOXO:US,BBG005CWWQG4,Stocks to watch during ASCO,2017-06-02 16:49:00 +0000,https://finance.yahoo.com/video/stocks-watch-during-asco-164900354.html?.tsrc=rss,"CNBC's Meg Tirrell reports on what stocks to watch during ASCO, the biggest cancer research conference in Chicago. The “Fast Money Halftime Report” traders weigh in."
LOXO,LOXO:US,BBG005CWWQG4,InPlay from Briefing.com,2017-05-30 10:57:08 +0000,https://finance.yahoo.com/news/inplay-briefing-com-115750752.html?.tsrc=rss,InPlay from Briefing.com
LOXO,LOXO:US,BBG005CWWQG4,"Loxo Oncology Announces FDA Clearance of Investigational New Drug (IND) Application for Next-Generation TRK Inhibitor, LOXO-195",2017-05-30 10:45:00 +0000,https://finance.yahoo.com/news/loxo-oncology-announces-fda-clearance-104500649.html?.tsrc=rss,"STAMFORD, Conn., May 30, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces Details of Two Larotrectinib Clinical Data Oral Presentations at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting,2017-05-17 21:00:00 +0000,https://finance.yahoo.com/news/loxo-oncology-announces-details-two-210000196.html?.tsrc=rss,"–Company to Host Conference Call and Webcast on Sunday, June 4 th at 5:30PM CT–. STAMFORD, Conn., May 17, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective ..."
LOXO,LOXO:US,BBG005CWWQG4,"Amid The Perceived Gloom In The Hedge Fund Universe, This Hedge Fund’s Stock Picks Gained 38.8% in Q1",2017-05-16 15:56:32 +0000,http://finance.yahoo.com/r/8f78967c-e2d3-3817-8f35-4e93a5f1ccbf/amid-the-perceived-gloom-in-the-hedge-fund-universe-this-hedge-funds-stock-picks-gained-38-8-in-q1-581248?yptr=yahoo&.tsrc=rss,"The dismal performance, redemptions and shuttering of some hedge funds have received significant media attention in the past two years. Given that the widely followed benchmark, the S&P 500, has been on an unprecedented bull run during this time, it is easy to mock the underperformers and complain about the exorbitant fees charged by hedge funds […]"
LOXO,LOXO:US,BBG005CWWQG4,InPlay from Briefing.com,2017-05-12 10:57:15 +0000,http://finance.yahoo.com/news/inplay-briefing-com-115750752.html?.tsrc=rss,InPlay from Briefing.com
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces FDA Orphan Drug Designation Granted to Larotrectinib for the Treatment of Solid Tumors with NTRK-Fusion Proteins,2017-05-12 10:45:00 +0000,http://finance.yahoo.com/news/loxo-oncology-announces-fda-orphan-104500681.html?.tsrc=rss,"STAMFORD, Conn., May 12, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology: FDA Grants Orphan Drug Designation To Larotrectinib,2017-05-12 08:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F2rAuW7_C0I/loxo-oncology-fda-grants-orphan-drug-designation-to-larotrectinib-20170512-00355,Loxo Oncology: FDA Grants Orphan Drug Designation To Larotrectinib
LOXO,LOXO:US,BBG005CWWQG4,"SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Loxo Oncology, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors",2017-05-10 11:01:00 +0000,http://finance.yahoo.com/news/shareholder-alert-purcell-julie-lefkowitz-110100168.html?.tsrc=rss,"NEW YORK, May 10, 2017 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim ..."
LOXO,LOXO:US,BBG005CWWQG4,"Loxo Oncology Announces Enrollment of First Patient in Phase 1 Clinical Trial for Highly Selective RET Inhibitor, LOXO-292",2017-05-10 10:45:00 +0000,http://finance.yahoo.com/news/loxo-oncology-announces-enrollment-first-104500017.html?.tsrc=rss,"STAMFORD, Conn., May 10, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo reports 1Q loss,2017-05-09 13:25:30 +0000,http://finance.yahoo.com/news/loxo-reports-1q-loss-132530682.html?.tsrc=rss,"On a per-share basis, the Stamford, Connecticut-based company said it had a loss of 96 cents. The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces First Quarter 2017 Financial Results,2017-05-09 10:45:00 +0000,http://finance.yahoo.com/news/loxo-oncology-announces-first-quarter-104500088.html?.tsrc=rss,"–Larotrectinib Late-Breaking Oral Presentation at ASCO Annual Meeting on June 3, 2017–. –Company to Host ASCO Conference Call and Webcast on June 4, 2017–. –$244.3 M in Cash, Cash Equivalents, and Investments ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology to Announce First Quarter 2017 Financial Results,2017-05-02 10:45:00 +0000,http://finance.yahoo.com/news/loxo-oncology-announce-first-quarter-104500690.html?.tsrc=rss,"STAMFORD, Conn., May 02, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, will announce financial ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces Acceptance of Larotrectinib Oral Presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting,2017-04-05 10:45:00 +0000,http://finance.yahoo.com/news/loxo-oncology-announces-acceptance-larotrectinib-104500592.html?.tsrc=rss,"STAMFORD, Conn., April 05, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced ..."
LOXO,LOXO:US,BBG005CWWQG4,Coverage initiated on Loxo Oncology by Morgan Stanley,2017-04-03 10:29:42 +0000,http://finance.yahoo.com/q/ud?s=LOXO,Coverage initiated on Loxo Oncology by Morgan Stanley
LOXO,LOXO:US,BBG005CWWQG4,"Setback For ACOR In Ampyra Suit, EARS Put On Notice, STDY On Steady Rise",2017-04-03 00:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5jI90mHkdz0/setback-for-acor-in-ampyra-suit-ears-put-on-notice-stdy-on-steady-rise-20170403-00002,"Setback For ACOR In Ampyra Suit, EARS Put On Notice, STDY On Steady Rise"
LOXO,LOXO:US,BBG005CWWQG4,4:36 pm Loxo Oncology reported proof of concept clinical data for larotrectinib in TRK fusion glioblastoma will be presented at the AACR,2017-04-02 20:36:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#loxo,4:36 pm Loxo Oncology reported proof of concept clinical data for larotrectinib in TRK fusion glioblastoma will be presented at the AACR
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces Proof of Concept Clinical Data for Larotrectinib in TRK Fusion Glioblastoma Presented at the AACR Annual Meeting 2017,2017-03-31 20:30:00 +0000,http://finance.yahoo.com/news/loxo-oncology-announces-proof-concept-203000489.html?.tsrc=rss,"STAMFORD, Conn., March 31, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces Proof of Concept Clinical Data for Larotrectinib in TRK Fusion Glioblastoma Presented at the AACR Annual Meeting 2017,2017-03-31 20:30:00 +0000,http://finance.yahoo.com/news/loxo-oncology-announces-proof-concept-203000489.html,"[GlobeNewswire] - STAMFORD, Conn., March 31, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced ..."
LOXO,LOXO:US,BBG005CWWQG4,"LOXO ONCOLOGY, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhib",2017-03-21 12:01:07 +0000,http://biz.yahoo.com/e/170321/loxo8-k.html,"LOXO ONCOLOGY, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhib"
LOXO,LOXO:US,BBG005CWWQG4,"Loxo Oncology Announces Larotrectinib Pan-TRK IHC Companion Diagnostic Collaboration with Ventana Medical Systems, Inc., a member of the Roche Group",2017-03-20 10:45:00 +0000,http://finance.yahoo.com/news/loxo-oncology-announces-larotrectinib-pan-104500298.html?.tsrc=rss,"STAMFORD, Conn., March 20, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced ..."
LOXO,LOXO:US,BBG005CWWQG4,"Loxo Oncology Announces Larotrectinib Pan-TRK IHC Companion Diagnostic Collaboration with Ventana Medical Systems, Inc., a member of the Roche Group",2017-03-20 10:45:00 +0000,http://finance.yahoo.com/news/loxo-oncology-announces-larotrectinib-pan-104500298.html,"[GlobeNewswire] - STAMFORD, Conn., March 20, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced ..."
LOXO,LOXO:US,BBG005CWWQG4,5 Stocks The Best Performing Hedge Funds Are Piling Into,2017-03-16 21:35:26 +0000,http://www.insidermonkey.com/blog/5-stocks-the-best-performing-hedge-funds-are-piling-into-2-567008/,5 Stocks The Best Performing Hedge Funds Are Piling Into
LOXO,LOXO:US,BBG005CWWQG4,5 Stocks The Best Performing Hedge Funds Are Piling Into,2017-03-16 21:35:26 +0000,http://finance.yahoo.com/r/43c33e41-c1ea-30c1-9a92-c0986007831c/5-stocks-the-best-performing-hedge-funds-are-piling-into-2-567008?yptr=yahoo&.tsrc=rss,"At Insider Monkey, we track more than 700 of the best hedge funds in the world and have developed various market-beating strategies over the years using the wealth of data we collect from their 13F filings. Our latest successful system is to select the 100 best-performing funds from the previous quarter and then identify their […]"
LOXO,LOXO:US,BBG005CWWQG4,"After Valeant, Here are 5 Drug Stocks Bill Ackman Should Buy Instead",2017-03-15 15:10:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5aHbc55hL50/after-valeant-here-are-5-drug-stocks-bill-ackman-should-buy-instead-cm761004,Billionaire investor Bill Ackman has finally decided to pull out his investment in Canada based drugmaker Valeant Pharmaceuticals International Inc VRX Hedge fund Pershing Square made the announcement earlier this week and said that while Ackman and Steve Fraidin will remain on the
LOXO,LOXO:US,BBG005CWWQG4,"After Valeant, Here are 5 Drug Stocks Bill Ackman Should Buy Instead",2017-03-15 13:22:01 +0000,http://finance.yahoo.com/news/valeant-5-drug-stocks-bill-132201437.html,"After Valeant, Here are 5 Drug Stocks Bill Ackman Should Buy Instead"
LOXO,LOXO:US,BBG005CWWQG4,"After Valeant, Here are 5 Drug Stocks Bill Ackman Should Buy Instead",2017-03-15 13:22:01 +0000,http://finance.yahoo.com/news/valeant-5-drug-stocks-bill-132201437.html?.tsrc=rss,"With Bill Ackman finally deciding to exit Valeant (VRX), here is a look at 5 Zacks Rank #1 and #2 drug stocks that the billionaire investor could consider buying."
LOXO,LOXO:US,BBG005CWWQG4,"LOXO ONCOLOGY, INC. Financials",2017-03-11 18:04:08 +0000,http://finance.yahoo.com/q/is?s=loxo,"LOXO ONCOLOGY, INC. Financials"
LOXO,LOXO:US,BBG005CWWQG4,Q4 2016 Loxo Oncology Inc Earnings Release - Before Market Open,2017-03-07 12:07:02 +0000,http://biz.yahoo.com/research/earncal/20170307.html?t=loxo,Q4 2016 Loxo Oncology Inc Earnings Release - Before Market Open
LOXO,LOXO:US,BBG005CWWQG4,Loxo reports 4Q loss,2017-03-07 11:56:53 +0000,http://finance.yahoo.com/news/loxo-reports-4q-loss-115653653.html?.tsrc=rss,"On a per-share basis, the Stamford, Connecticut-based company said it had a loss of $1.28. The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo reports 4Q loss,2017-03-07 11:56:53 +0000,http://sg.finance.yahoo.com/news/loxo-reports-4q-loss-115653563.html,Loxo reports 4Q loss
LOXO,LOXO:US,BBG005CWWQG4,"LOXO ONCOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib",2017-03-07 11:46:27 +0000,http://biz.yahoo.com/e/170307/loxo8-k.html,"LOXO ONCOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib"
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Reports Fourth Quarter and Year-End 2016 Financial Results,2017-03-07 11:45:00 +0000,http://finance.yahoo.com/news/loxo-oncology-reports-fourth-quarter-114500739.html,"[GlobeNewswire] - STAMFORD, Conn., March 07, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today reported ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Reports Fourth Quarter and Year-End 2016 Financial Results,2017-03-07 11:45:00 +0000,http://finance.yahoo.com/news/loxo-oncology-reports-fourth-quarter-114500739.html?.tsrc=rss,"STAMFORD, Conn., March 07, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today reported ..."
LOXO,LOXO:US,BBG005CWWQG4,"Pre-Market Earnings Report for March 7, 2017 :  DKS, MIK, MOMO, KLXI, NAV, LOXO, LGIH, AMID, LMOS, AVDL, ACRE, DQ",2017-03-06 21:12:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gvhbqnzQuTY/pre-market-earnings-report-for-march-7-2017-dks-mik-momo-klxi-nav-loxo-lgih-amid-lmos-avdl-acre-dq-cm756864,The following companies are expected to report earnings prior to market open on 03 07 2017 Visit our Earnings Calendar for a full list of expected earnings releases Dick s Sporting Goods Inc DKS is reporting for the quarter ending January 31 2017 The
LOXO,LOXO:US,BBG005CWWQG4,Should You Sell Loxo Oncology (LOXO) Before Earnings?,2017-03-03 16:15:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kcXwiDzwhb0/should-you-sell-loxo-oncology-loxo-before-earnings-cm755967,Investors are always looking for stocks that are poised to beat at earnings season and Loxo Oncology Inc LOXO may be one such company The firm has earnings coming up pretty soon and events are shaping up quite nicely for their report That is because Loxo Oncology is seeing
LOXO,LOXO:US,BBG005CWWQG4,Should You Sell Loxo Oncology (LOXO) Before Earnings?,2017-03-03 13:50:01 +0000,http://finance.yahoo.com/news/sell-loxo-oncology-loxo-earnings-135001566.html,Should You Sell Loxo Oncology (LOXO) Before Earnings?
LOXO,LOXO:US,BBG005CWWQG4,Should You Sell Loxo Oncology (LOXO) Before Earnings?,2017-03-03 13:50:01 +0000,http://finance.yahoo.com/news/sell-loxo-oncology-loxo-earnings-135001566.html?.tsrc=rss,"Investors are always looking for stocks that are poised to beat at earnings season and Loxo Oncology, Inc. (LOXO) may be one such company."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology to Present at Cowen and Company 37th Annual Health Care Conference,2017-03-01 11:45:00 +0000,http://finance.yahoo.com/news/loxo-oncology-present-cowen-company-114500498.html?.tsrc=rss,"STAMFORD, Conn., March 01, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology to Present at Cowen and Company 37th Annual Health Care Conference,2017-03-01 11:45:00 +0000,http://finance.yahoo.com/news/loxo-oncology-present-cowen-company-114500498.html,"[GlobeNewswire] - STAMFORD, Conn., March 01, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology to Announce Fourth Quarter and Year-End 2016 Financial Results,2017-02-28 11:45:00 +0000,http://finance.yahoo.com/news/loxo-oncology-announce-fourth-quarter-114500858.html?.tsrc=rss,"STAMFORD, Conn., Feb. 28, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, will announce financial ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology to Announce Fourth Quarter and Year-End 2016 Financial Results,2017-02-28 11:45:00 +0000,http://finance.yahoo.com/news/loxo-oncology-announce-fourth-quarter-114500858.html,"[GlobeNewswire] - STAMFORD, Conn., Feb. 28, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, will announce financial ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces Completion of Clinical Trial Enrollment for Larotrectinib NDA Primary Efficacy Analysis,2017-02-21 11:45:00 +0000,http://finance.yahoo.com/news/loxo-oncology-announces-completion-clinical-114500940.html,"[GlobeNewswire] - STAMFORD, Conn., Feb. 21, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces Completion of Clinical Trial Enrollment for Larotrectinib NDA Primary Efficacy Analysis,2017-02-21 11:45:00 +0000,http://finance.yahoo.com/news/loxo-oncology-announces-completion-clinical-114500940.html?.tsrc=rss,"STAMFORD, Conn., Feb. 21, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced ..."
LOXO,LOXO:US,BBG005CWWQG4,"Purcell Julie & Lefkowitz LLP is Investigating Loxo Oncology, Inc. for Potential Breaches of Fiduciary Duty by its Board of Directors",2017-02-08 22:45:00 +0000,http://finance.yahoo.com/news/purcell-julie-lefkowitz-llp-investigating-224500619.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / February 8, 2017 / Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary ..."
LOXO,LOXO:US,BBG005CWWQG4,"Purcell Julie & Lefkowitz LLP is Investigating Loxo Oncology, Inc. for Potential Breaches of Fiduciary Duty by its Board of Directors",2017-02-08 22:45:00 +0000,http://finance.yahoo.com/news/purcell-julie-lefkowitz-llp-investigating-224500619.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / February 8, 2017 / Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary ..."
LOXO,LOXO:US,BBG005CWWQG4,"Huge Michael Dell Purchase Highlights Insider Buying: Dell Technologies, Accelerate Diagnostics, Loxo Oncology and More",2017-01-15 15:10:01 +0000,http://finance.yahoo.com/news/huge-michael-dell-purchase-highlights-151001940.html,"Huge Michael Dell Purchase Highlights Insider Buying: Dell Technologies, Accelerate Diagnostics, Loxo Oncology and More"
LOXO,LOXO:US,BBG005CWWQG4,"Huge Michael Dell Purchase Highlights Insider Buying: Dell Technologies, Accelerate Diagnostics, Loxo Oncology and More",2017-01-15 15:10:01 +0000,http://finance.yahoo.com/news/huge-michael-dell-purchase-highlights-151001940.html?.tsrc=rss,"With the first earnings starting to hit the tape last week, the windows for insiders at public companies are starting to slam shut. Volume was nothing compared to in the weeks leading up to the end of ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces the Closing of its Follow-On Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares,2017-01-10 21:30:00 +0000,http://finance.yahoo.com/news/loxo-oncology-announces-closing-offering-213000116.html,"[GlobeNewswire] - STAMFORD, Conn., Jan. 10, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced ..."
LOXO,LOXO:US,BBG005CWWQG4,One of The Largest Hedge Funds In The World Is Betting On Loxo Oncology Inc. (LOXO),2017-01-08 16:06:21 +0000,http://www.insidermonkey.com/blog/one-of-the-largest-hedge-funds-in-the-world-is-betting-on-loxo-oncology-inc-nasdaqloxo-515056/,One of The Largest Hedge Funds In The World Is Betting On Loxo Oncology Inc. (LOXO)
LOXO,LOXO:US,BBG005CWWQG4,One of The Largest Hedge Funds In The World Is Betting On Loxo Oncology Inc. (LOXO),2017-01-08 16:06:21 +0000,http://finance.yahoo.com/r/6ef9075c-4079-3428-8c1e-c33c15e58fa2/one-of-the-largest-hedge-funds-in-the-world-is-betting-on-loxo-oncology-inc-nasdaqloxo-515056?yptr=yahoo&.tsrc=rss,"One of the largest hedge funds in the world is betting on Loxo Oncology Inc. (NASDAQ:LOXO), a biopharmaceuticals company that develops and sells medicine to treat certain types of cancer. Boston based Adage Capital disclosed a 1.35 million share position in Loxo Oncology. The hedge fund held only 817K shares of Loxo at the end […]"
LOXO,LOXO:US,BBG005CWWQG4,"LOXO ONCOLOGY, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and Financi",2017-01-05 21:03:06 +0000,http://biz.yahoo.com/e/170105/loxo8-k.html,"LOXO ONCOLOGY, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and Financi"
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Prices Follow-On Offering of Common Stock,2017-01-05 12:34:07 +0000,http://www.publicnow.com/view/2FA60C98EE259DC1C012B1489B7331921BCF16E1,"[at noodls] - STAMFORD, Conn., Jan. 05, 2017 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Prices Follow-On Offering of Common Stock,2017-01-05 11:45:00 +0000,http://finance.yahoo.com/news/loxo-oncology-prices-offering-common-114500707.html,"[GlobeNewswire] - STAMFORD, Conn., Jan. 05, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces Proposed Public Offering of Common Stock,2017-01-04 21:33:13 +0000,http://www.publicnow.com/view/831E656266B7AA6FD641C11A12D6FABD776B2602,"[at noodls] - STAMFORD, Conn., Jan. 04, 2017 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces Proposed Public Offering of Common Stock,2017-01-04 21:01:00 +0000,http://finance.yahoo.com/news/loxo-oncology-announces-proposed-public-210100481.html,"[GlobeNewswire] - STAMFORD, Conn., Jan. 04, 2017-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, announced today ..."
LOXO,LOXO:US,BBG005CWWQG4,John Paulson Continues to Buy These 8 Stocks,2016-12-23 20:53:01 +0000,http://finance.yahoo.com/news/john-paulson-continues-buy-8-205301457.html,John Paulson Continues to Buy These 8 Stocks
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology (LOXO) Surges: Stock Moves 25.8% Higher,2016-12-20 16:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lNSg_IqTlO4/loxo-oncology-loxo-surges-stock-moves-258-higher-cm723941,Loxo Oncology Inc LOXO was a big mover last session as its shares rose almost 26 on the day The move came after the company announced a comprehensive program update for larotrectinib LOXO 101 a selective inhibitor of tropomyosin receptor kinase TRK and its pipeline drug
LOXO,LOXO:US,BBG005CWWQG4,Can Loxo Oncology Inc (LOXO) Candidate Larotrectinib Pass Regulatory Test?,2016-12-20 15:44:04 +0000,http://www.insidermonkey.com/blog/can-loxo-oncology-inc-loxo-candidate-larotrectinib-pass-regulatory-test-512243/,Can Loxo Oncology Inc (LOXO) Candidate Larotrectinib Pass Regulatory Test?
LOXO,LOXO:US,BBG005CWWQG4,Can Loxo Oncology Inc (LOXO) Candidate Larotrectinib Pass Regulatory Test?,2016-12-20 15:44:04 +0000,http://finance.yahoo.com/r/05a4099e-c4af-3a41-963f-eb28b0d2f8bd/can-loxo-oncology-inc-loxo-candidate-larotrectinib-pass-regulatory-test-512243?yptr=yahoo&.tsrc=rss,"Loxo Oncology Inc (NASDAQ:LOXO) is targeting to file for regulatory approval of its gene mutation cancer drug candidate larotrectinib at the end of next year or early in 2018. But is that mission possible? A closer look at Loxo’s update on larotrectinib suggests the target is within reach. For instance, the company said that enrollment […]"
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology (LOXO) Surges: Stock Moves 25.8% Higher,2016-12-20 13:25:01 +0000,http://finance.yahoo.com/news/loxo-oncology-loxo-surges-stock-132501346.html?.tsrc=rss,"Loxo Oncology, Inc. (LOXO) moved big last session, as its shares jumped almost 26% on the day."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology (LOXO) Surges: Stock Moves 25.8% Higher,2016-12-20 13:25:01 +0000,http://finance.yahoo.com/news/loxo-oncology-loxo-surges-stock-132501346.html,Loxo Oncology (LOXO) Surges: Stock Moves 25.8% Higher
LOXO,LOXO:US,BBG005CWWQG4,Why Loxo Oncology Stock Soared As Much As 36% Today,2016-12-19 22:57:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g0S5PJj7dEs/why-loxo-oncology-stock-soared-as-much-as-36-today-cm723629,Image source Getty Images What happened Shares of rare cancer specialist Loxo Oncology NASDAQ LOXO were shot out of a cannon Monday morning after the company provided a clinical update on three of its product candidates The stock hit an intraday and all time
LOXO,LOXO:US,BBG005CWWQG4,"Health Care Sector Update for 12/19/2016: LOXO,PULM,RNVA",2016-12-19 21:36:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xykK94OXUwE/health-care-sector-update-for-12192016-loxopulmrnva-cm723605,Top Health Care StocksTop Health Care Stocks JNJ 0 24 JNJ 0 24 PFE 0 09 PFE 0 09 MRK 0 50 MRK 0 50 ABT 2 26 ABT 2 26 AMGN 1 18 AMGN 1 18 Health care stocks turned solidly lower this afternoon giving back prior gains and the NYSE Health Care Index falling about 0 4 while shares
LOXO,LOXO:US,BBG005CWWQG4,Why Loxo Oncology Stock Soared As Much As 36% Today,2016-12-19 21:15:45 +0000,http://www.fool.com/investing/2016/12/19/why-loxo-oncology-stock-soared-as-much-as-36-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Loxo Oncology Stock Soared As Much As 36% Today
LOXO,LOXO:US,BBG005CWWQG4,Why Loxo Oncology Stock Soared As Much As 36% Today,2016-12-19 21:15:45 +0000,http://finance.yahoo.com/r/c82c8e50-f94d-39b9-b5f3-09105313ea2f/why-loxo-oncology-stock-soared-as-much-as-36-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2&yptr=yahoo&.tsrc=rss,The early-stage biopharma updated investors on three of its four leading product candidates.
LOXO,LOXO:US,BBG005CWWQG4,"LOXO ONCOLOGY, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits",2016-12-19 21:08:53 +0000,http://biz.yahoo.com/e/161219/loxo8-k.html,"LOXO ONCOLOGY, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits"
LOXO,LOXO:US,BBG005CWWQG4,"CLVS Gets FDA Nod, PBYI Leaves Big Board, LOXO Hits All-time High, CNAT On Watch",2016-12-19 20:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9I2-LeJFKKM/clvs-gets-fda-nod-pbyi-leaves-big-board-loxo-hits-alltime-high-cnat-on-watch-20161219-01000,"CLVS Gets FDA Nod, PBYI Leaves Big Board, LOXO Hits All-time High, CNAT On Watch"
LOXO,LOXO:US,BBG005CWWQG4,"Monday Sector Leaders: Drugs, Communicationss Services",2016-12-19 19:57:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4gWTZa3z_8I/monday-sector-leaders-drugs-communicationss-services-cm723511,In trading on Monday drugs shares were relative leaders up on the day by about 1 8 Leading the group were shares of Loxo Oncology LOXO up about 33 8 and shares of MannKind MNKD up about 16 3 on the day Also showing relative strength are communicationss services shares up
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Outlines Plans for Accelerated Path to U.S. FDA Approval for Larotrectinib (LOXO-101) and Provides Comprehensive Pipeline Update,2016-12-19 12:41:07 +0000,http://www.publicnow.com/view/58F4520B7111050193780050FF4B13C7F217FCF7,[at noodls] - - Larotrectinib Approximately 85% Enrolled to Goal; Completion of Enrollment for Primary Efficacy Analysis Expected Early 2017 - - NDA Submission for Larotrectinib Expected Late 2017 or Early 2018 - - ...
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Aims for Genetic Mutation Cancer Drug Approval in 2018,2016-12-19 12:31:00 +0000,https://www.thestreet.com/story/13930234/1/loxo-oncology-aims-for-genetic-mutation-cancer-drug-approval-in-2018.html?puc=yahoo&cm_ven=YAHOO,Loxo Oncology Aims for Genetic Mutation Cancer Drug Approval in 2018
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Inc. (LOXO) Is Surging After Update On Larotrectinib,2016-12-19 09:41:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e50RRzF9zRE/loxo-oncology-inc-loxo-is-surging-after-update-on-larotrectinib-20161219-00493,Loxo Oncology Inc. (LOXO) Is Surging After Update On Larotrectinib
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology TRK Inhibitor Larotrectinib (LOXO-101) Shows Durable Anti-Tumor Activity Across TRK Fusion Cancers in ESMO Asia Phase 1 Update,2016-12-18 10:10:09 +0000,http://www.publicnow.com/view/38640A728E5E4F01377EDF40639DA5897973AD7D,[at noodls] - - Six of Seven TRK Fusion Patients Achieve Confirmed RECIST Partial Responses and All Remain in Response - - All TRK Fusion Patients Remain on Study With Median Follow-Up of 15 Cycles - - Company to Host ...
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Updates Results From Adult Phase 1 Trial Of Larotrectinib,2016-12-18 09:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CG_FxQ2tua8/loxo-oncology-updates-results-from-adult-phase-1-trial-of-larotrectinib-20161218-00005,Loxo Oncology Updates Results From Adult Phase 1 Trial Of Larotrectinib
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology to Present Updated LOXO-101 Adult Phase 1 Data at the European Society for Medical Oncology (ESMO) Asia Congress,2016-12-12 11:45:00 +0000,http://finance.yahoo.com/news/loxo-oncology-present-updated-loxo-114500318.html,"[GlobeNewswire] - –Company to Host Investor Conference Call and Webcast on Monday, December 19, 2016–. STAMFORD, Conn., Dec. 12, 2016-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly ..."
LOXO,LOXO:US,BBG005CWWQG4,Is Loxo Oncology Inc (LOXO) Worthy of Your Portfolio?,2016-12-11 13:46:26 +0000,http://www.insidermonkey.com/blog/is-loxo-oncology-inc-loxo-worthy-of-your-portfolio-505517/,Is Loxo Oncology Inc (LOXO) Worthy of Your Portfolio?
LOXO,LOXO:US,BBG005CWWQG4,"Loxo Oncology, Inc. :LOXO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016",2016-11-28 19:19:21 +0000,http://www.capitalcube.com/blog/index.php/loxo-oncology-inc-loxo-us-earnings-analysis-q3-2016-by-the-numbers-november-28-2016/,"Loxo Oncology, Inc. :LOXO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016"
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology to Present Preclinical Data for LOXO-292 and LOXO-195 at the 28th EORTC-NCI-AACR Symposium,2016-11-15 11:45:00 +0000,http://finance.yahoo.com/news/loxo-oncology-present-preclinical-data-114500542.html,"[GlobeNewswire] - STAMFORD, Conn., Nov. 15, 2016-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced ..."
LOXO,LOXO:US,BBG005CWWQG4,"Loxo Oncology Appoints Steve D. Harr, M.D., CFO of Juno Therapeutics, to Board of Directors",2016-11-09 11:59:08 +0000,http://www.publicnow.com/view/50B8F5399245318D7A9B3ABFE26D30ABBD3C5E69,"[at noodls] - STAMFORD, Conn., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically ..."
LOXO,LOXO:US,BBG005CWWQG4,"LOXO ONCOLOGY, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits",2016-11-09 11:56:40 +0000,http://biz.yahoo.com/e/161109/loxo8-k.html,"LOXO ONCOLOGY, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits"
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology to Present at the Stifel 2016 Healthcare Conference,2016-11-08 11:45:00 +0000,http://finance.yahoo.com/news/loxo-oncology-present-stifel-2016-114500139.html,"[GlobeNewswire] - STAMFORD, Conn., Nov. 08, 2016-- Loxo Oncology, Inc., a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, today announced ..."
LOXO,LOXO:US,BBG005CWWQG4,Q3 2016 Loxo Oncology Inc Earnings Release - Before Market Open,2016-11-02 11:07:03 +0000,http://biz.yahoo.com/research/earncal/20161102.html?t=loxo,Q3 2016 Loxo Oncology Inc Earnings Release - Before Market Open
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces Third Quarter 2016 Financial Results,2016-11-02 11:00:10 +0000,http://www.publicnow.com/view/FABDCE42902747A3FDADB9D90EBD39295AA54F86,"[at noodls] - - Updated LOXO-101 Phase 1 Clinical Data Accepted for Oral Presentation at ESMO Asia on December 18, 2016 - - Company to Provide LOXO-101 Program and Pipeline Update During Conference Call and Webcast ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo reports 3Q loss,2016-11-02 10:53:28 +0000,http://sg.finance.yahoo.com/news/loxo-reports-3q-loss-105328658.html,Loxo reports 3Q loss
LOXO,LOXO:US,BBG005CWWQG4,"LOXO ONCOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib",2016-11-02 10:46:13 +0000,http://biz.yahoo.com/e/161102/loxo8-k.html,"LOXO ONCOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib"
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology to Announce Third Quarter 2016 Financial Results,2016-10-26 11:05:08 +0000,http://www.publicnow.com/view/538EE881A63C4C0D71EEE41AD99178C807FFCEBA,"[at noodls] - STAMFORD, Conn., Oct. 26, 2016 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically ..."
LOXO,LOXO:US,BBG005CWWQG4,"RS Investment Exits LogMeIn, HMS Holdings in 3rd Quarter",2016-10-04 21:42:39 +0000,http://finance.yahoo.com/news/rs-investment-exits-logmein-hms-214239730.html,"RS Investment Exits LogMeIn, HMS Holdings in 3rd Quarter"
LOXO,LOXO:US,BBG005CWWQG4,"Loxo Oncology, Inc. :LOXO-US: Earnings Analysis: Q2, 2016 By the Numbers : September 13, 2016",2016-09-13 19:23:36 +0000,http://www.capitalcube.com/blog/index.php/loxo-oncology-inc-loxo-us-earnings-analysis-q2-2016-by-the-numbers-september-13-2016/,"Loxo Oncology, Inc. :LOXO-US: Earnings Analysis: Q2, 2016 By the Numbers : September 13, 2016"
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology to Present at Upcoming Investor Conferences,2016-09-01 10:53:08 +0000,http://www.publicnow.com/view/5591D755827C669263519BF9C5B8896C8F4008D3,"[at noodls] - STAMFORD, Conn., Sept. 01, 2016 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo reports 2Q loss,2016-08-03 12:29:27 +0000,http://sg.finance.yahoo.com/news/loxo-reports-2q-loss-122927810.html,Loxo reports 2Q loss
LOXO,LOXO:US,BBG005CWWQG4,Q2 2016 Loxo Oncology Inc Earnings Release - Before Market Open,2016-08-03 11:07:04 +0000,http://biz.yahoo.com/research/earncal/20160803.html?t=loxo,Q2 2016 Loxo Oncology Inc Earnings Release - Before Market Open
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces Second Quarter 2016 Financial Results,2016-08-03 11:02:11 +0000,http://www.publicnow.com/view/EC9378EB29290A78CB3B87D5EE804E602D5C420D,"[at noodls] - STAMFORD, Conn., Aug. 03, 2016 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically ..."
LOXO,LOXO:US,BBG005CWWQG4,"LOXO ONCOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib",2016-08-03 10:46:53 +0000,http://biz.yahoo.com/e/160803/loxo8-k.html,"LOXO ONCOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib"
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology to Announce Second Quarter 2016 Financial Results,2016-07-27 11:08:10 +0000,http://www.publicnow.com/view/E0A919732E9E933645DE80E78EBDFB0917813856,"[at noodls] - STAMFORD, Conn., July 27, 2016 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically ..."
LOXO,LOXO:US,BBG005CWWQG4,"Why Brocade Communications, Loxo Oncology, and Acadia Healthcare Slumped Today",2016-07-15 01:08:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LkaUNDq_Py8/why-brocade-communications-loxo-oncology-and-acadia-healthcare-slumped-today-cm649553,"Image source  Brocade Communications.  Thursday was another strong day for the stock market, and the Dow and S&P 500 continued their recent climbs to new record highs. Stocks are generally maintaining a balancing"
LOXO,LOXO:US,BBG005CWWQG4,"Why Brocade Communications, Loxo Oncology, and Acadia Healthcare Slumped Today",2016-07-14 23:14:00 +0000,http://www.fool.com/investing/2016/07/14/why-brocade-communications-loxo-oncology-and-acadi.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Brocade Communications, Loxo Oncology, and Acadia Healthcare Slumped Today"
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology (LOXO) Looks Good: Stock Adds 6% in Session,2016-07-14 13:57:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4SfrVddnO3o/loxo-oncology-loxo-looks-good-stock-adds-6-in-session-cm649091,"Loxo Oncology, Inc.LOXO was a big mover last session, as the company saw its shares rise nearly 6% on the day. The company revealed that the Food and Drug Administration has granted Breakthrough Therapy Designation to its selective inhibitor"
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology (LOXO) Looks Good: Stock Adds 6% in Session,2016-07-14 12:00:12 +0000,http://finance.yahoo.com/news/loxo-oncology-loxo-looks-good-120012553.html,Loxo Oncology (LOXO) Looks Good: Stock Adds 6% in Session
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Gets Breakthrough Therapy Status From FDA For LOXO-101,2016-07-13 14:45:30 +0000,http://finance.yahoo.com/news/loxo-oncology-gets-breakthrough-therapy-144530379.html,Loxo Oncology Gets Breakthrough Therapy Status From FDA For LOXO-101
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for LOXO-101,2016-07-13 13:28:07 +0000,http://www.publicnow.com/view/1DB4B756A878B45EE2D2430DEACBE44278092BE0,"[at noodls] - STAMFORD, Conn., July 13, 2016 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Accepts Invitation to Present LOXO-101 to the FDA’s Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee,2016-06-15 13:09:05 +0000,http://www.publicnow.com/view/5B28D0C13751F6BE48C3E59E345321B8E8EF900D,"[at noodls] - STAMFORD, Conn., June 15, 2016 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology to Present at the JMP Securities Life Sciences Conference,2016-06-14 10:59:08 +0000,http://www.publicnow.com/view/826C608D3A639CCE2EC342E7F2A7AD1F32F30CBD,"[at noodls] - STAMFORD, Conn., June 14, 2016 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically ..."
LOXO,LOXO:US,BBG005CWWQG4,"LOXO ONCOLOGY, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of",2016-06-13 20:32:09 +0000,http://biz.yahoo.com/e/160613/loxo8-k.html,"LOXO ONCOLOGY, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of"
LOXO,LOXO:US,BBG005CWWQG4,"Loxo Oncology, Inc. :LOXO-US: Earnings Analysis: Q1, 2016 By the Numbers : June 2, 2016",2016-06-02 16:57:53 +0000,http://www.capitalcube.com/blog/index.php/loxo-oncology-inc-loxo-us-earnings-analysis-q1-2016-by-the-numbers-june-2-2016/,"Loxo Oncology, Inc. :LOXO-US: Earnings Analysis: Q1, 2016 By the Numbers : June 2, 2016"
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces the Closing of its Follow-On Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares,2016-05-17 21:02:03 +0000,http://www.publicnow.com/view/7B2BC34F303F9B32AE1E48EA5D8A4AC922E2DDE5,"[at noodls] - STAMFORD, Conn., May 17, 2016 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined ..."
LOXO,LOXO:US,BBG005CWWQG4,"LOXO ONCOLOGY, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statement",2016-05-12 10:04:03 +0000,http://biz.yahoo.com/e/160512/loxo8-k.html,"LOXO ONCOLOGY, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statement"
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Prices Follow-On Offering of Common Stock,2016-05-12 01:07:03 +0000,http://www.publicnow.com/view/B63AF860F49BFD51BC2582D187C33C889F758F36,"[at noodls] - Released OnMay 11, 2016 View PDF STAMFORD, Conn., May 11, 2016 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces Proposed Public Offering of Common Stock,2016-05-11 21:07:13 +0000,http://www.publicnow.com/view/4A2AB239CBEFEA3E8A1A6F1D6945AB6876EFAF2A,"[at noodls] - Released OnMay 11, 2016 View PDF STAMFORD, Conn., May 11, 2016 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces First Quarter 2016 Financial Results,2016-05-04 11:10:08 +0000,http://www.publicnow.com/view/5E74D580C1C86A4C8B09FEC455EC142208A9A0E3,"[at noodls] - Released OnMay 4, 2016 View PDF STAMFORD, Conn., May 04, 2016 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo reports 1Q loss,2016-05-04 10:54:35 +0000,http://sg.finance.yahoo.com/news/loxo-reports-1q-loss-105435131.html,Loxo reports 1Q loss
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology to Announce First Quarter 2016 Financial Results,2016-04-27 11:01:45 +0000,http://www.publicnow.com/view/26F6158F7D56157822A586B7A24F5B69B44BF9AD,"[at noodls] - Released OnApr 27, 2016 View PDF STAMFORD, Conn., April 27, 2016 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines ..."
LOXO,LOXO:US,BBG005CWWQG4,What A Toddler And Her Tumor Can Teach Us About Cancer Research,2016-04-19 13:31:00 +0000,http://www.forbes.com/sites/matthewherper/2016/04/19/what-a-toddler-and-her-tumor-can-teach-us-about-cancer-research/?utm_campaign=yahootix&partner=yahootix,What A Toddler And Her Tumor Can Teach Us About Cancer Research
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces First Pediatric Response to LOXO-101,2016-04-19 13:15:06 +0000,http://www.publicnow.com/view/D0F5487963AB68E3951E5EA6544221BBE0A3AF61,"[at noodls] - Released OnApr 19, 2016 View PDF - Peer-Reviewed Case Report Published in Pediatric Blood and Cancer - - LOXO-101 Induces 90 Percent Tumor Regression in Toddler with Refractory Infantile Fibrosarcoma; ..."
LOXO,LOXO:US,BBG005CWWQG4,"LOXO ONCOLOGY, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits",2016-04-18 10:08:14 +0000,http://biz.yahoo.com/e/160418/loxo8-k.html,"LOXO ONCOLOGY, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits"
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology TRK Inhibitor LOXO-101 Shows Durable Anti-Tumor Activity Across TRK Fusion Cancers in AACR Phase 1 Update,2016-04-17 21:26:56 +0000,http://www.publicnow.com/view/89FA46890FF72BF713D30F1B170790BC45823AAD,"[at noodls] - Released OnApr 17, 2016 View PDF - Five of Six Evaluable Patients with TRK Fusion Cancers Achieve Confirmed RECIST Partial Responses; All Six Demonstrate Significant Tumor Regressions - - All TRK Fusion ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Cancer Drug Targets Gene Mutation With Durable Responses in Early Study,2016-04-17 21:17:00 +0000,http://www.thestreet.com/story/13533127/1/loxo-cancer-drug-targets-gene-mutation-with-durable-responses-in-early-study.html?puc=yahoo&cm_ven=YAHOO,Loxo Cancer Drug Targets Gene Mutation With Durable Responses in Early Study
LOXO,LOXO:US,BBG005CWWQG4,We're on the verge of seeing cancer in a drastically different light,2016-04-17 21:15:00 +0000,http://finance.yahoo.com/news/were-verge-seeing-cancer-drastically-211500042.html,We're on the verge of seeing cancer in a drastically different light
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology to Present Updated LOXO-101 Phase 1 Data at the 2016 AACR Annual Meeting,2016-04-11 14:41:10 +0000,http://www.publicnow.com/view/14928F86135F287C854A8EBE6050FC9BAED9DD86,"[at noodls] - Released OnApr 11, 2016 View PDF - Company to Host Investor Conference Call and Webcast on Monday, April 18, 2016 - STAMFORD, Conn., April 11, 2016 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology (LOXO) Looks Good: Stock Adds 7% in Session,2016-04-01 14:30:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Sl99RM5ythk/loxo-oncology-loxo-looks-good-stock-adds-7-in-session-cm600428,"Loxo Oncology, Inc. LOXO was a big mover last session, as the company saw its shares rise 7% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This breaks"
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology (LOXO) Looks Good: Stock Adds 7% in Session,2016-04-01 12:40:12 +0000,http://finance.yahoo.com/news/loxo-oncology-loxo-looks-good-124012896.html,Loxo Oncology (LOXO) Looks Good: Stock Adds 7% in Session
LOXO,LOXO:US,BBG005CWWQG4,Loxo reports 4Q loss,2016-03-15 11:07:47 +0000,http://sg.finance.yahoo.com/news/loxo-reports-4q-loss-110747319.html,Loxo reports 4Q loss
LOXO,LOXO:US,BBG005CWWQG4,Should You Sell Loxo Oncology (LOXO) Before Earnings?,2016-03-11 16:32:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T-aoT73V3z0/should-you-sell-loxo-oncology-loxo-before-earnings-cm592000,"Investors are always looking for stocks that are poised to beat at earnings season and Loxo Oncology, Inc.LOXO may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for"
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces EMA Orphan Drug Designation Granted to LOXO-101 for Treatment of Soft Tissue Sarcoma,2016-01-15 12:12:01 +0000,http://www.noodls.com/view/9C98B934170321C0AE107E50F4ABABFB699ECE47,"[at noodls] - Released OnJan 15, 2016 View PDF , (GLOBE NEWSWIRE) -- (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces First Patient Enrolled in Phase 1 Trial of LOXO-101 in Pediatric Cancer Patients,2015-12-22 12:20:11 +0000,http://www.noodls.com/view/CCBB2CB1F43F84E6B8223ED8408E99B4781B6E6D,"[at noodls] - Released OnDec 22, 2015 View PDF , (GLOBE NEWSWIRE) -- (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, ..."
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces the Closing of Its Follow-On Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares,2015-11-17 21:59:38 +0000,http://www.noodls.com/view/538C9B76AF8CEFD97DD5FC8574E4EF4038950A90,[at noodls] - Loxo Oncology Announces the Closing of Its Follow-On Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology to Present at Upcoming Investor Conferences,2015-11-10 12:16:19 +0000,http://www.noodls.com/view/8BF657A5AAA7D77688BA611CF0A49E3249CE5B99,[at noodls] - Loxo Oncology to Present at Upcoming Investor Conferences
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology Announces Third Quarter 2015 Financial Results and Provides Program Updates,2015-11-10 12:16:19 +0000,http://www.noodls.com/view/72096A78BE53E25DFABB486AA02DDD4D5C033456,[at noodls] - Loxo Oncology Announces Third Quarter 2015 Financial Results and Provides Program Updates
LOXO,LOXO:US,BBG005CWWQG4,Loxo reports 3Q loss,2015-11-10 11:55:43 +0000,http://sg.finance.yahoo.com/news/loxo-reports-3q-loss-115543067.html,Loxo reports 3Q loss
LOXO,LOXO:US,BBG005CWWQG4,"Monday Sector Leaders: Biotechnology, Drugs",2015-11-09 19:53:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qTe6VywCwHc/monday-sector-leaders-biotechnology-drugs-cm541039,"In trading on Monday, biotechnology shares were relative leaders, up on the day by about 0.2%. Leading the group were shares of Curis ( CRIS ), up about 10% and shares of Biocryst Pharmaceuticals ( BCRX ) up about"
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology (LOXO) in Focus: Stock Up 9.1% in Session,2015-09-25 14:41:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GDCwEUzuPa4/loxo-oncology-loxo-in-focus-stock-up-91-in-session-cm524027,"Loxo Oncology, Inc. ( LOXO ) was a big mover last session, as the company saw its shares rise over 9% on the day. The move came on solid volume too with far more shares changing hands than in"
LOXO,LOXO:US,BBG005CWWQG4,"Health Care Sector Update for 07/28/2015: LOXO,CYTR,IMMU",2015-07-28 20:27:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ApAQ-fHMkdA/health-care-sector-update-for-07282015-loxocytrimmu-cm502139,"Top Health Care Stocks JNJ +0.78% PZE +2.93% MRK +0.34% ABT +1.05% AMGN +4.77% Health care stocks were still broadly higher today, with the NYSE Health Care Sector Index over about 1.1% and shares of health care companies in"
LOXO,LOXO:US,BBG005CWWQG4,"Loxo Oncology (LOXO) Shares March Higher, Can It Continue?  - Tale of the Tape",2015-06-25 13:31:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RpoUpxnv4XA/loxo-oncology-loxo-shares-march-higher-can-it-continue-tale-of-the-tape-cm490439,"As of late, it has definitely been a great time to be an investor in Loxo Oncology Inc ( LOXO ) . The stock has moved higher by 69.2% in the past month, while it is also above its"
LOXO,LOXO:US,BBG005CWWQG4,Loxo Oncology (LOXO) Jumps: Stock Moves 9.7% Higher - Tale of the Tape,2015-06-22 14:33:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JfIwD_4G_vU/loxo-oncology-loxo-jumps-stock-moves-97-higher-tale-of-the-tape-cm489159,"Loxo Oncology, Inc. ( LOXO ) was a big mover last session, as its shares rose almost 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session."
LOXO,LOXO:US,BBG005CWWQG4,Can the Rally in Loxo Oncology (LOXO) Shares Continue? - Tale of the Tape,2015-06-02 15:38:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CdChNeaM5FU/can-the-rally-in-loxo-oncology-loxo-shares-continue-tale-of-the-tape-cm482641,"Loxo Oncology Inc ( LOXO ) has been on the move lately as the stock has risen by 7.2% in the past four weeks, and it is currently trading well above its 20 Day SMA. This is a pretty"
LOXO,LOXO:US,BBG005CWWQG4,"Wednesday Sector Leaders: Drugs, Biotechnology Stocks",2014-09-24 20:58:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8cuAf-es0pA/wednesday-sector-leaders-drugs-biotechnology-stocks-cm394635,"In trading on Wednesday, drugs shares were relative leaders, up on the day by about 1.6%. Leading the group were shares of Lipocine ( LPCN ), up about 44.1% and shares of Loxo Oncology ( LOXO ) up about"
LOXO,LOXO:US,BBG005CWWQG4,"Loxo Oncology prices upsized IPO at $13, the midpoint of the range",2014-08-01 13:34:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JWyRF1Pzzlg/loxo-oncology-prices-upsized-ipo-at-13-the-midpoint-of-the-range-cm375766,"Loxo Oncology, an early stage biotech developing targeted therapies to treat solid tumors, raised $68 million by offering 5.3 million shares (vs. 4.4 million originally planned) at $13, the midpoint of the $12 to $14 range. Loxo"
LOXO,LOXO:US,BBG005CWWQG4,Cancer biotech Loxo Oncology sets terms for $57 million IPO,2014-07-21 22:45:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RHu4bEY_Moo/cancer-biotech-loxo-oncology-sets-terms-for-57-million-ipo-cm372009,"Loxo Oncology, a biotech developing small molecule therapeutics to treat solid tumors, announced terms for its IPO on Monday. The Stamford, CT based company plans to raise $57 million by offering 4.4 million shares at a price"
LOXO,LOXO:US,BBG005CWWQG4,Cancer biotech Loxo Oncology files for a $69 million IPO,2014-07-05 22:48:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5Ap4L1iizkw/cancer-biotech-loxo-oncology-files-for-a-69-million-ipo-cm366528,"Loxo Oncology, which is developing small molecule therapeutics for the treatment of solid tumors, filed on Monday with the SEC to raise up to $69 million in an initial public offering. The Stamford, CT based company, which"
